Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.640
+0.090 (1.98%)
Nov 21, 2024, 1:29 PM EST - Market open
Verve Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 393 | 1,121 | 1,192 | 1,776 | - | - |
| Market Cap Growth | -51.53% | -5.95% | -32.88% | - | - | - |
| Enterprise Value | -83 | 713 | 721 | 1,389 | - | - |
| Last Close Price | 4.55 | 13.94 | 19.35 | 36.87 | - | - |
| PS Ratio | 15.00 | 95.35 | 614.13 | - | - | - |
| PB Ratio | 0.76 | 1.87 | 2.16 | 4.97 | - | - |
| P/TBV Ratio | 0.81 | 1.87 | 2.16 | 4.97 | - | - |
| EV/Sales Ratio | - | 60.61 | 371.58 | - | - | - |
| Debt / Equity Ratio | 0.14 | 0.12 | 0.15 | 0.01 | - | 1.61 |
| Asset Turnover | 0.04 | 0.02 | 0.00 | - | - | - |
| Quick Ratio | 12.72 | 17.02 | 15.84 | 16.37 | 9.86 | 5.29 |
| Current Ratio | 13.05 | 17.24 | 16.05 | 16.67 | 10.11 | 5.36 |
| Return on Equity (ROE) | -40.67% | -34.78% | -34.66% | -57.48% | -136.07% | - |
| Return on Assets (ROA) | -22.19% | -19.48% | -19.48% | -23.53% | -50.75% | - |
| Return on Capital (ROIC) | -25.35% | -21.34% | -20.87% | -25.88% | -66.17% | - |
| Earnings Yield | -51.71% | -17.85% | -13.20% | -6.77% | - | - |
| FCF Yield | -42.54% | -14.17% | -11.37% | -4.63% | - | - |
| Buyback Yield / Dilution | -29.46% | -18.79% | -101.04% | -1094.26% | -76.18% | - |
| Total Shareholder Return | -29.46% | -18.79% | -101.04% | -1094.26% | -76.18% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.